11/07/2024
6:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:16 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/22/2024
5:06 PM | Akebia Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/22/2024
7:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
6:36 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
11:15 PM | Akebia Therapeutics (Filer)
| Form EFFECT | |
08/08/2024
6:52 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
08/08/2024
6:06 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
5:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:31 PM | Akebia Therapeutics (Issuer)
Akebia Therapeutics (Issuer)
Ostrowski Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
4:37 PM | Akebia Therapeutics (Issuer)
Ostrowski Erik (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2024
8:03 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
3:18 PM | ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:18 PM | Akebia Therapeutics (Issuer)
ZUMWALT LEANNE M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:19 PM | Akebia Therapeutics (Issuer)
FRIESON RON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:19 PM | Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:19 PM | Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:20 PM | Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:20 PM | Akebia Therapeutics (Issuer)
Wolf Myles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:04 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:05 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
6:17 PM | Akebia Therapeutics (Subject)
Hadas Nicole R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
6:19 PM | Akebia Therapeutics (Subject)
Dahan Michel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
4:27 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:03 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:05 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
4:17 PM | Akebia Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
4:18 PM | Akebia Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
4:19 PM | Akebia Therapeutics (Filer)
| Form ARS | |
04/23/2024
7:32 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
6:33 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
4:19 PM | Akebia Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2024
4:48 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:49 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:46 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:47 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:00 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:01 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:02 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:03 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:32 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
02/27/2024
5:11 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:14 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:16 PM | Akebia Therapeutics (Subject)
Dahan Michel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:19 PM | Akebia Therapeutics (Subject)
Hadas Nicole R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:00 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
3:52 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
3:40 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
7:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
4:21 PM | Akebia Therapeutics (Issuer)
Grund Nicholas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/18/2024
3:21 PM | Akebia Therapeutics (Issuer)
Malabre Richard C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2024
7:02 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free AKBA Stock Alerts